1. Saslow, D., et al. (2007). American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. C CA: A Cancer Journal for Clinicians, 57(1), 7–28.
2. Markowitz, L. E., et al. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recommendations and Reports, 56(RR-2), 1–24.
3. Committee on Infectious Diseases. (2012). HPV vaccine recommendations. Pediatrics, 129(3), 602–605.
4. Centers for Disease Control and Prevention. (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report, 59(20), 626–629.
5. American College of Obstetricians and Gynecologists. (2010). Committee opinion no. 467: Human papillomavirus vaccination. Obstetrics & Gynecology, 116(3), 800–803.